Completed EARLY_PHASE1 INTERVENTIONAL 4-arm NCT06426537

Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches

A Comparative Study of Colchicine's Role in Reducing Cardiac Fibrosis in Acute Myocardial Infarction Patients: Evaluating Outcomes With Percutaneous Coronary Intervention Versus Without Reperfusion

Sponsor: University of Brawijaya

Conditions ST-Elevation Myocardial Infarction

Interventions Colchicine 0.5 MG Oral Tablet

Updated 4 times since 2024 Last updated: May 22, 2024 Started: Oct 20, 2022 Primary completion: Mar 25, 2023 Completion: Nov 20, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates ST-Elevation Myocardial Infarction and is currently completed. University of Brawijaya leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed EARLY_PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jun 2024 — Jul 2024 [monthly]

Completed EARLY_PHASE1

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Brawijaya

Data source: University of Brawijaya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tulungagung, Indonesia